Tiffany Price
Doctor of Philosophy in Pharmaceutical Sciences (PhD)
Examining anticholinergic effects on disease progression and survival outcomes in patients diagnosed with amyotrophic lateral sclerosis (ALS)
Review details about the recently announced changes to study and work permits that apply to master’s and doctoral degree students. Read more
If you are passionate about health sciences research that makes a difference in people's lives, you're in good hands. We offer award-wining graduate programs led by world-class researchers. You'll have access to top-tier facilities and be working alongside the best and brightest in the field, conducting research that addresses real life problems. Our paradigm-changing approach is collaborative, innovative, and results-driven.
We're tackling diseases like asthma / chronic obstructive pulmonary disease, diabetes, cancer, heart disease, and arthritis. We're developing better ways to deliver drugs and prevent adverse drug reactions. And we're conducting clinical and economic research in pharmaceutical outcomes.
Our reputation as a top research centre attracts some of the brightest and most productive minds in the field. Our faculty includes Canada Research Chairs, Michael Smith Foundation for Health Research Scholars and Senior Scholars, and Distinguished University Scholars.
We are innovators in pharmacy education, research and practice, with the goal of supporting the optimization of drug therapy in the pursuit of improved patient outcomes.
adMare BioInnovations is located in our building. It is an independent, non-profit organization with a focus on bridging the gap between academic discoveries in the health sciences and the development of new medicines to treat human disease. The Faculty partners with adMare BioInnovations to provide unique research and mentoring opportunities for MSc and PhD students.
We are also home to several sophisticated research centres that specialize in the areas of human genome and exome sequencing, and health outcomes research.
Opened in 2012, the Pharmaceutical Sciences Building at UBC is a state-of-the-art learning and research facility. The building houses modern, modular labs designed specifically for the type of research intended for the space. Our classroom facilities are fitted with advanced technology to facilitate new modes of learning.
Measuring 246,000 square feet, it's an eye-catching addition to our campus, and has drawn attention and admiration from around the world—including 15 awards of excellence.
As a leading research faculty, we conduct ground-breaking research in the pharmaceutical sciences – all with the goal of addressing the pressing health needs of society and improving lives. Our research activities centre around four areas of focus.
This theme covers our activities in epidemiological analysis, health outcomes and health economics research seeking solutions for the predictive enhancement of intervention strategies for practical and preventive healthcare. The impact of this work is used to shape policy to optimize the allocation of health care resources as well as defining the efficacy of healthcare interventions and strategy.
This highly interdisciplinary theme embodies research directed at the interactions of therapeutic agents with human cells, and covers fundamental questions of the mechanisms of the drug action through to the behaviour of drugs in human systems. These studies are used to inform and optimize the development and delivery of drug intervention regimes for clinical practice and the pharmaceutical industry.
This theme applies our expertise in the chemical biology of the fabrication and handling of nanoscopic materials to drug discovery and delivery. Sensing and screening technologies are also an important focus.
Our research in this theme addresses the issue of scholarship in pharmacy and the pharmaceutical sciences with a view to augment our educational research capacity and enhance the methodologies of teaching practice, student learning and curriculum decision-making.
| Name | Research Interests |
|---|---|
| Beedle, Aaron | |
| Cairns, Brian | electrophysiology; headache; Neuropharmacology; Oro-Facial Pain; pain; pain mechanisms; peripheral analgesics; sex-related differences; temporomandibular disorders; Electrophysiology, Headache, Neuropharmacology, Oro-Facial Pain, Pain, Pain mechanisms, Peripheral analgesics, Sex-related differences, Temporomandibular disorders |
| Chang, Thomas | Nuclear receptors are evolutionarily-related DNA-binding transcription factors that regulate the expression of a broad array of genes involved in various biological processes |
| Cheng, Miffy | nanomedicine; gene therapy to combat chronic diseases; nanomedicine, gene therapy to combat chronic diseases |
| Conklin, Annalijn | Social Determinants of Dietary and Metabolic Disorders; social nutritional epidemiology; women's health; Health Equity; Chronic Diseases in Elderly; Obesity; CVD risk factors; healthy ageing; food and nutrition policy; Indigenous health; Community Health / Public Health; disease management evaluation; healthcare quality improvement; Social Determinants of Dietary and Metabolic Disorders, Social nutritional epidemiology, Women's Health, Health equity, Chronic Diseases in Elderly, Obesity, CVD risk factors, Healthy ageing, Food and nutrition policy, Indigenous health, Community Health / Public Health, Disease management evaluation, Healthcare quality improvement |
| Coughtrie, Michael | Drug metabolizing enzymes |
| Cragg, Jacquelyn | data science; open science; Causal inference; Drug Effectiveness; Drug Safety; Epidemiology; neuro-epidemiology; Neurological diseases; Spinal cord injury; Amyotrophic Lateral Sclerosis (ALS); multiple sclerosis; Parkinson’s disease; data science, open science, causal inference, drug effectiveness, drug safety, epidemiology, neuro-epidemiology, neurological diseases, spinal cord injury, amyotrophic lateral sclerosis (ALS), multiple sclerosis, Parkinson’s disease |
| De Vera, Mary | examining how eHealth technologies can support new and existing models of care to improve care delivery and patient outcomes; exploring patients' perspectives and experiences with medication taking and adherence; and evaluating the use and impacts of medications among pregnant women, particularly with inflammatory conditions. |
| Finbloom, Joel | nanomedicine; Chemical Biology; drug delivery; Pharmaceutical Sciences; Infectious disease; Bacterial Biofilms; Microbiome; Probiotics; Antibiotic resistance; Nanomedicine, Chemical Biology, Drug Delivery, Pharmaceutical Sciences, Infectious Disease, Bacterial Biofilms, Microbiome, Probiotics, Antibiotic Resistance |
| Frankel, Adam | Protein Biochemistry; arginine methylation; Histones; Nucleosomes; post-translational modifications; Biological and Biochemical Mechanisms; Organic Molecules and Biomolecules; Bioactive Molecules; Proteins; Chemical Biology; drug discovery; Target Engagement; Amino acids; Protein biochemistry, Arginine methylation, Histones, Nucleosomes, Post-translational modifications, Biological and Biochemical Mechanisms, Organic Molecules and Biomolecules, Bioactive Molecules, Proteins, Chemical biology, Drug discovery, Target engagement, Amino acids |
| Giaever, Guri | Model organisms, human therapeutics, high-throughput cell biology, drug synergy, technologies for understanding relationship between chromatic structure and transcriptional regulation |
| Harrison, Mark | measurement and valuation of health, health technology and policy assessment, and preferences for healthcare interventions; evaluation/re-evaluation of the type of health care that is provided, the point in the treatment pathway, and the way in which it is delivered |
| Jarvis-Selinger, Sandra | Education, human learning, development, and instruction, education innovation, konwledge translation, teaching excellence, curriculum design, technology |
| Johnson, Kate | Health economics; Health outcomes; Epidemiology; Health Economics, Health Outcomes, Epidemiology |
| Krentz, Nicole | Diabetes; Developmental biology; Genetics; Diabetes, Developmental Biology, Genetics |
| Kumar, Ujendra | Somatostatin hormone, molecular pharmacology, Somatostatin, , Hormones, somatostatin, locomotor and cognitive function, neurodegenerative diseases, drugs |
| Lalji, Fawziah | Pharmacoepidemiology; Infectious diseases; Immunization; Antibiotics and Resistance; Vaccine preventable diseases; Pharmacoepidemiology, Infectious Diseases, Immunization, Antibiotics and Resistance, Vaccine preventable diseases |
| Li, Shyh-Dar | biopharmaceutics; drug delivery; nanomedicine; pharmaceutics; Gene delivery and therapy; Regenerative medicine; Localized drug delivery; Biopharmaceutics, Drug delivery, Nanomedicine, Pharmaceutics, Gene delivery and therapy, Regenerative medicine, Localized drug delivery |
| Loewen, Peter | atrial fibrillation; Pharmacoepidemiology; Thrombosis and Embolism; adherence to medication; Cardiovascular diseases; Arrhythmia; Heart Failure; stroke; Health Care Technologies; Professional Practices; Hematology; decision making; clinical prediction rules; hospital pharmacy practice; knowledge translation of evidence to patient care; patient complexiometry; patient decision aids; patient education; pharmacy practice; prediction of stroke and bleeding in atrial fibrillation patients; quality of care, quality drug therapy; Shared decision-making; stroke prevention therapy; use of mobile technology for clinical decision-making; Atrial fibrillation, Pharmacoepidemiology, Thrombosis and Embolism, Adherence to medication, Cardiovascular Diseases, Arrhythmia, Heart Failure, Stroke, Health Care Technologies, Professional Practices, Hematology, Decision Making, Clinical prediction rules, Hospital pharmacy practice, Knowledge translation of evidence to patient care, Patient complexiometry, Patient decision aids, Patient education, Pharmacy practice, Prediction of stroke and bleeding in atrial fibrillation patients, Quality of care, quality drug therapy, Shared decision-making, Stroke prevention therapy, Use of mobile technology for clinical decision-making |
| Lynd, Larry | health economics, orphan drugs, pharmaceutical policy, respiratory medicine, epidemiology, pharmacoepidemiology, rare diseases |
| Maharaj, Anil | Pharmacometrics; Pharmacokinetics/Pharmacodynamics; Obstetric and Pediatric Pharmacology; Pharmacometrics, Pharmacokinetics/Pharmacodynamics, Obstetric and Pediatric Pharmacology |
| McCormack, James | Knowledge translation and evidence-based practice; Knowledge translation and evidence-based practice |
| Nislow, Corey | genomics; Genetics; drug discovery; Biotechnology; Space Biology; Genomics, genetics, Drug Discovery, Biotechnology, Space Biology |
| Page, Brent | Cell Signaling and Cancer; Cancer; Cell signaling; Chemical Biology; Drug development; Drug Discovery, Design and Delivery; Medicinal Chemistry; Target Engagement; Cell Signaling and Cancer, Cancer, Cell Signaling, Chemical Biology, Drug Development, Drug Discovery, Design and Delivery, Medicinal Chemistry, Target Engagement |
| Raman-Wilms, Lalitha |